− Curetis adds six new trial sites, significantly expanding U.S. clinical trial network for ongoing FDA study
Holzgerlingen, Germany, May 14, 2014 -- Curetis AG, a developer of next-level molecular diagnostic solutions, today announced that Robin Patel, M.D., Professor of Medicine
− Curetis adds six new trial sites, significantly expanding U.S. clinical trial network for ongoing FDA study
Holzgerlingen, Germany, May 14, 2014 -- Curetis AG, a developer of next-level molecular diagnostic solutions, today announced that Robin Patel, M.D., Professor of Medicine